“The compound SR-17018 is the first biased agonist on the mu opioid receptor that does not lead to tolerance with chronic use,” says Stahl, a senior team scientist during the Bohn lab. “This can be a desirable characteristic for prospective use within the context of Serious, critical soreness.” Wow https://williamd626zkr1.thenerdsblog.com/profile